CIK 0000897448
- Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +353 16699020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-31 | THERO JOHN F President and CEO | Shares withheld for taxes | −143,177 | $16.94 | $2.4M | 2,337,428 |
| 2019-01-31 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −120,000 | 0 | ||
| 2019-01-31 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −119,667 | 119,666 | ||
| 2019-01-31 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −123,667 | 247,333 | ||
| 2019-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +2,604 | $1.40 | $4K | 343,901 |
| 2019-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +4,167 | $2.50 | $10K | 348,068 |
| 2019-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +2,770 | $2.95 | $8K | 350,838 |
| 2019-01-31 | Ketchum Steven B Chief Scientific Officer | Sale | −9,541 | $17.49 | $167K | 341,297 |
| 2019-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +26,666 | 367,963 | ||
| 2019-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +29,000 | 396,963 | ||
| 2019-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +26,000 | 422,963 | ||
| 2019-01-31 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −40,482 | $16.94 | $686K | 382,481 |
| 2019-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −2,604 | 31,250 | ||
| 2019-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −4,167 | 20,831 | ||
| 2019-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −2,770 | 67,000 | ||
| 2019-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −26,666 | 0 | ||
| 2019-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −29,000 | 29,000 | ||
| 2019-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −26,000 | 52,000 | ||
| 2019-01-31 | Kennedy Joseph T General Counsel | Option exercise | +1,953 | $1.02 | $2K | 1,953 |
| 2019-01-31 | Kennedy Joseph T General Counsel | Option exercise | +2,604 | $1.40 | $4K | 4,557 |
Page 72 of 95 · 1,885 trades